Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study.
about
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte deathTriggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate.In vitro induction of erythrocyte phosphatidylserine translocation by the natural naphthoquinone shikonin.Piperlongumine-induced phosphatidylserine translocation in the erythrocyte membraneAdhesion of annexin 7 deficient erythrocytes to endothelial cellsConjugated bilirubin triggers anemia by inducing erythrocyte death.Identification of signalling cascades involved in red blood cell shrinkage and vesiculation.Triggering of suicidal erythrocyte death by penta-O-galloyl-β-D-glucose.Breakdown of phosphatidylserine asymmetry following treatment of erythrocytes with lumefantrine.Ceramide in the regulation of eryptosis, the suicidal erythrocyte death.Stimulation of erythrocyte cell membrane scrambling by mushroom tyrosinase.Effect of thioridazine on erythrocytes.Triggering of suicidal erythrocyte death by celecoxib.Carmustine-induced phosphatidylserine translocation in the erythrocyte membrane.Stimulation of suicidal erythrocyte death by ribavirin.Fluoxetine induced suicidal erythrocyte death.Effect of dermaseptin on erythrocytes.Effect of chloride channel inhibitors on cytosolic Ca2+ levels and Ca2+-activated K+ (Gardos) channel activity in human red blood cells.Effect of nitazoxanide on erythrocytes.Ceranib-2-induced suicidal erythrocyte death.Enhanced suicidal erythrocyte death in acute cardiac failure.Suicidal erythrocyte death in end-stage renal disease.Dynamic adhesion of eryptotic erythrocytes to immobilized platelets via platelet phosphatidylserine receptors.
P2860
Q26852497-FEE0E015-D7A2-4530-9B07-BACD0A42C335Q31142636-5CE1CF9A-2C7D-47D2-BCF9-3557A61CF7F6Q33736525-7F6CD11F-925A-4342-9697-7499019DBD38Q34411483-B16E4EA2-5D97-49DD-B905-5CBEEC8753BCQ34599179-2F6DA34F-71FE-473E-A0F0-7C154F031AE1Q35004454-9712F6FF-DE94-4F86-A91E-65F14924CAC5Q35574674-D0DA0656-0769-4EFA-8E31-A4D09E6C4FF8Q37576167-074A5BFB-3B3C-4CC4-A830-ADDC0246AC14Q37617809-A373B2EC-5B72-44E2-9DD3-65D42DBBA7C9Q38338337-360C54C7-881B-431B-ABBC-71F3E4555340Q38544259-EE3BC6A7-FB69-4BA4-AA7A-2858789B4350Q42032476-E2C4D2EF-E346-4240-9F36-F38D5731F097Q42146863-932E50B2-4C42-4FC7-BCC9-818B2769C0A3Q42181197-9DDD647D-E832-4022-88F4-E81F4D512C7FQ42259397-55140CA8-1909-447F-911B-E900356B2A79Q42545154-82478742-701E-46F0-AA13-D4B5F3582E60Q43758708-49E8BDB2-F9B4-4F88-879F-2520DFD90C54Q45341231-440B9253-559B-439E-99B6-7EF7085F8C0CQ45882294-DE82959D-7F98-4472-88B1-21AC82002F61Q46533820-E06D0F9E-9A9A-48E2-B695-F5138C7E5F46Q46652210-301AD185-78E4-4D02-AF50-E2744E0F1B5CQ46904253-37273AD8-A7EF-41A8-A9AA-22FE4AE28332Q54524513-E14FE85C-9CAB-49BD-AE0B-45B6A4B29781
P2860
Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Enhanced erythrocyte membrane ...... an in vivo and in vitro study.
@en
Enhanced erythrocyte membrane ...... an in vivo and in vitro study.
@nl
type
label
Enhanced erythrocyte membrane ...... an in vivo and in vitro study.
@en
Enhanced erythrocyte membrane ...... an in vivo and in vitro study.
@nl
prefLabel
Enhanced erythrocyte membrane ...... an in vivo and in vitro study.
@en
Enhanced erythrocyte membrane ...... an in vivo and in vitro study.
@nl
P2093
P2860
P356
P1476
Enhanced erythrocyte membrane ...... an in vivo and in vitro study.
@en
P2093
Adrian Lupescu
Ansgar Plate
Christine Zelenak
Elisabeth Lang
Florian Lang
Kashif Jilani
Michael Bitzer
Michael Föller
Mohanad Zbidah
Nazneen Shaik
P2860
P304
P356
10.1159/000341465
P577
2012-08-20T00:00:00Z